Inclusion body myositis in a patient with long standing rheumatoid arthritis treated with anti-TNFα and rituximab

@article{Vordenbaeumen2009InclusionBM,
  title={Inclusion body myositis in a patient with long standing rheumatoid arthritis treated with anti-TNFα and rituximab},
  author={Stefan Vordenbaeumen and Eva Neuen-Jacob and Jutta Richter and Matthias Schneider},
  journal={Clinical Rheumatology},
  year={2009},
  volume={29},
  pages={555-558}
}
Adult inflammatory myopathies are rare conditions. Amongst them, inclusion body myositis (IBM) is considered to be the most common acquired myopathy in adults above 50 years of age, follows a slowly progressive course, and ultimately leads to severe disability. The case of a 57-year-old patient with long standing rheumatoid arthritis (RA) who developed muscle wasting and weakness of the quadriceps femoris after initiation of anti-TNFα treatment is presented. Further workup including muscle… CONTINUE READING